|
8291 |
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
Enthalten in The journal of headache and pain Bd. 15, 27.9.2014, Nr. 1, date:12.2014: 1-6
|
|
|
|
8292 |
Two randomized, double-blind, placebo-controlled, dose-escalation phase 1 studies evaluating BTH1677, a 1, 3–1,6 beta glucan pathogen associated molecular pattern, in healthy volunteer subjects
Enthalten in Investigational new drugs Bd. 34, 11.2.2016, Nr. 2, date:4.2016: 202-215
|
|
|
|
8293 |
Tyrosinkinase-Hemmer bei breitem Fibrosepektrum effektiv
Enthalten in Pneumo news Bd. 12, 16.3.2020, Nr. 2, date:3.2020: 12-13
|
|
|
|
8294 |
Ubiquinol (reduced Coenzyme Q10) in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled, pilot trial
Enthalten in Critical care Bd. 19, 1.7.2015, Nr. 1, date:12.2015: 1-11
|
|
|
|
8295 |
Ubiquinol supplementation enhances peak power production in trained athletes: a double-blind, placebo controlled study
Enthalten in Proceedings of the ... International Society of Sports Nutrition (ISSN) Conference and Expo Bd. 10, 29.4.2013, Nr. 1, date:12.2013: 1-8
|
|
|
|
8296 |
Ubrogepant zur Behandlung akuter Migräneattacken
Enthalten in Schmerzmedizin Bd. 37, 23.9.2021, Nr. 5, date:9.2021: 20-21
|
|
|
|
8297 |
Über die Harnsäure auch den Blutdruck senken?
Enthalten in Rheuma plus Bd. 17, 12.2.2018, Nr. 1, date:2.2018: 14-15
|
|
|
|
8298 |
Überraschend hohe Responderraten
Enthalten in Info Neurologie & Psychiatrie Bd. 20, 22.1.2018, Nr. 1, date:1.2018: 25
|
|
|
|
8299 |
ÜBRIGENS
Enthalten in CME Bd. 14, 14.8.2017, Nr. 7-8, date:8.2017: 38
|
|
|
|
8300 |
Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial
Enthalten in Reproductive sciences Bd. 25, 1.2.2018, Nr. 2, date:2.2018: 198-206
|
|
Administration
